The human CYP3A subfamily is of interest due to its multiplicity, activity toward known carcinogens, and extrahepatic expression. These results show that there is considerable heterogeneity in the expression of the CYP3A subfamily in human gastrointestinal tissues. (Gut 1995; 36: 259-267) 
Abstract
The human CYP3A subfamily is of interest due to its multiplicity, activity toward known carcinogens, and extrahepatic expression. In situ hybridisation analysis of formalin fixed, routinely processed biopsy specimens was used to localise CYP3A mRNA in human gastrointestinal tissues from several individuals. CYP3A mRNA is abundant in human liver and in mucosal epithelial cells of all segments of the human small intestine. RNA blot analyses showed that the mRNA species observed in most livers and in human small intestine represent CYP3A3I3A4 represents one of a group of heterocyclic amine compounds formed during the cooking of protein containing foods.9 10 Many of these compounds are highly mutagenic in the Ames test, and induce tumours in a number of species at several sites.9 10 In the absence of flavonoids, the activation of these compounds is primarily attributed to members of the CYPIA subfamily in both lower animals and humans. 1 1-14 The gastrointestinal tract represents a major portal of entry for many carcinogens. Indeed, Ames et al have estimated that more than 90% of the chemicals to which humans are exposed are dietary-derived and must therefore traverse the gastrointestinal tract. ' tEey te S S r < * ; . s : l l z w . # . s -s :
' . * ŝrx > * s 4 ; 4 > g a : S S t ' . . , . . , . , . ' g . ' 4 W + * : , r ' 4 ' o B < g ; * . t ' > ' . ; < * * . * ; t j j j i % * t # i 4 * . ' ; # . . > , < 0 $ i . r S 2 w w N S { a . . . . . ; s X : : . F N ks 4 2w us>.ts t* 9; s v , ,--w : .: B.i;-,ua | | | S , ' S , . t . t ' . . . t 4 _ . S # , t r ; * . S ' , , * l S l ' . , 2 S , < a i protein had been expressed were included on these immunoblots as standards. A representative immunoblot is shown in Figure 5 . The single band observed in microsomes prepared from human ileum and jejunum co-migrated with both the CYP3A3/3A4 band routinely observed in all human livers and the cDNAexpressed CYP3A4 protein band. As CYP3A3 and CYP3A4 cannot be electrophoretically separated using SDS-PAGE, these data show that one or both of these enzymes, rather than CYP3A5, represents a major constitutive enzyme in the human small intestine.
The CYP3A4 RNA probe was used to localise CYP3A mRNA in formalin fixed, paraffin embedded sections from various segments of the human gastrointestinal tract using in situ hybridisation. All test sections were evaluated by direct comparison with a control section probed with a CYP3A4 sense RNA probe. In situ hybridisation analyses were also correlated with immunohistochemical studies using an anti-CYP3A3 polyclonal IgG for further verification. Autoradiographic grains indicating the presence of CYP3A mRNA were observed on sections of human oesophagus, small intestine, and colon but not on sections of human stomach. The level of signal was highest in the small intestine. Analysis of sections of oesophagus from four individuals showed CYP3A mRNA in all cases. The level of signal was variable but was lower than observed in the small intestine. Figure 6 (A) shows a representative section of human oesophagus probed with the CYP3A4 sense probe while a serial section probed with the CYP3A4 antisense probe is shown under conventional and dark field illumination in Figure 6 , (B) and (C) respectively. As expected from the RNA blot results, appreciable levels of autoradiographic grains were observed on sections prepared from all segments of the human small intestine. Autoradiographic grains were localised to the surface columnar absorptive cells throughout the human small intestine with grain density highest at the tips of the villi. In contrast, few grains were observed in Goblet cells and the epithelial cells of the crypts of Lieberkuhn. Brunner's glands also showed grain levels not appreciably higher than background. Some interindividual variation was observed in the level of autoradiographic signal on sections, particularly in the jejunum. A representative control section of a duodenal biopsy probed with a CYP3A4 sense RNA probe is shown in Figure 7(A) . A test section probed with the antisense RNA probe, clearly showing CYP3A mRNA, is shown under both conventional illumination and dark field illumination in Figure 7 , (B) and (C) respectively.
Whereas an abundance of autoradiographic signal was observed on analysis of all human small intestine sections, analysis of colon sections from several individuals produced more variable results. Autoradiographic signal indicating the presence of CYP3A mRNA was localised to mucosal epithelial cells on colonic biopsy sections from eight of 10 individuals studied. The level of autoradiographic signal observed on these sections was extrei variable but was reduced relative to routinely observed on sections of s intestine. A representative control colon bi section probed with the CYP3A4 sense l probe is shown in Figure 8(A) . A col section probed with the CYP3A4 antis RNA probe is shown under conventional dark field illumination in Figure 8, (B A radiographic signal was also observec rectum but at levels lower than elsewhe: the colon. 
ACTIVATION OF DIETARY HETEROCYCLIC AMINES BY EXPRESSED CYP3A4 AND CYP3A5
To pursue the possibility that CYP3A enzymes, when expressed in gastrointestinal tissues, may play a role in dietary promutagen activation, human CYP3A4 and CYP3A5 were expressed in a COS cell expression system as described in the methods section. Immunodetection of the COS cell-expressed CYP3A proteins by goat anti-human CYP3A3 IgG is evident from the immunoblot featured in Figure 5 . The activity of CYP3A4 and CYP3A5 was then determined toward two dietary heterocyclic amines, PhIP and MeIQ, in the Ames Salmonella test. Neither CYP3A enzyme exhibited activity toward PhIP in the absence or presence of 100 ,uM a-naphthoflavone (data not shown). The capacity of CYP3A4 and CYP3A5 to activate the heterocyclic amine MeIQ is shown in Table II . In the absence of ot-naphthoflavone, both CYP3A4 and CYP3A5 possessed minimal mwn activity toward MeIQ. This activity increased 9.) 16 fold (CYP3A4) and 10 fold (CYP3A5) with the addition of 100 ,uM ox-naphthoflavone. No mely activity towards PhIP or MeIQ was observed that in cell lysates prepared from COS cells ;mall transfected with the expression vector iopsy p91023(B) lacking a CYP3A insert. RNA Ionic ;ense Discussion and We have used a variety of techniques to study 1 (C) the expression of the CYP3A subfamily in the Lphic human gastrointestinal tract. Using the in situ tions hybridisation technique, CYP3A expression lyses was shown in human liver, oesophagus, duofrom denum, jejunum, ileum, and all segments of sent, the colon. The zonal pattern of CYP3A lents mRNA localisation in human liver and all areas rerse, of the small intestine correlated with the tuto-immunohistochemical findings of Murray d in et al 28 38 indicating that the previously re in observed zonal distribution of CYP3A protein in these tissues is secondary to differences in mRNA levels. 47 48 The identification of colonic CYP3A expression in a large number of subjects in this study probably reflects the excellent sensitivity of both the in situ hybridisation and RNA blotting techniques employing RNA probes. The demonstration of CYP3A expression by both techniques required long autoradiographic exposures indicating the relatively low level of expression in this tissue. The interindividual heterogeneity in CYP3A expression observed in the colon did not correlate with gender or the anatomical location within the colon. Indeed, in individuals in whom CYP3A mRNA was observed in colon by RNA blotting, in situ hybridisation analysis of segments of caecum, ascending colon, transverse colon, descending colon, and sigmoid colon confirmed expression along the whole length of the colon. While the heterogeneity in colonic CYP3A mRNA may reflect genetic variations in CYP3A expression, these differences may be a result of differential induction of the various CYP3A enzymes. While drug histories obtained for these individuals were incomplete, there was no evidence that any subject was undergoing therapy with known inducers of the CYP3A subfamily.
In a previous study we showed that a potential interaction involving CYP3A enzymes may exist between the dietary heterocyclic amines and flavonoids consumed in the diet.8 This earlier study demonstrated the capacity of microsomes prepared from rabbit and human small intestine to activate the heterocyclic amine MeIQ in the presence of flavonoids. We postulated that such an interaction may be due to activation of MeIQ by CYP3A enzymes. Confirmation of this hypothesis and its potential importance in humans required both the further characterisation of gastrointestinal CYP3A expression, as described in the present report, and a demonstration that members of the CYP3A subfamily were capable of carrying out this process. To explore this latter possibility we expressed two members of the CYP3A subfamily from their respective cDNAs and determined their activity toward two dietary heterocylic amines, PhIP and MeIQ, in the presence and absence of the flavonoid ao-naphthoflavone. These two compounds were selected as PhIP represents the most abundant of the heterocyclic amine compounds found in cooked meat while MeIQ exhibits far greater mutagenicity.9 10 In the present study we have shown that the capacity of both CYP3A4 and CYP3A5 to activate MeIQ to a mutagen is increased significantly in the presence of cxnaphthoflavone. In contrast, no activity was observed for either CYP3A4 or CYP3A5 towards PhIP. The demonstration that expressed CYP3A4 and CYP3A5 proteins are indeed able to activate MeIQ to a mutagen in the presence of ao-naphthoflavone supports the hypothesis that CYP3A proteins are responsible for the flavonoid inducible MeIQ activation observed with small intestine microsomes. 8 The significance of such an interaction in the aetiology of human cancer is unclear, however, given that most human gastrointestinal cancers occur in the colorectal region yet CYP3A expression is greater in the small intestine.
This study again shows the utility of the in situ hybridisation technique for investigating cytochrome P450 expression in human tissues. The analysis of cytochrome P450 expression in human tissues is often difficult because of the multiplicity of cytochromes P450 and limited availability of human tissues. In situ hybridisation, when complemented with RNA blotting studies, obviates many of these difficulties and is therefore particularly suited to analysis of cytochrome P450 expression.
The technique provides precise spatial information not possible with conventional blotting techniques and also offers excellent sensitivity. We have previously shown the suitability of the in situ hybridisation technique for localising cytochrome P450 mRNA in routinely processed formalin fixed, paraffin embedded tissue sections.33 This enables retrospective studies of P450 expression in a range of both normal and pathological tissues. The ability to use routine biopsy specimens is particularly useful for studies of gastrointestinal expression given the frequency of biopsy procedures in these tissues. The present study shows many of the advantages of in situ hybridisation enabling a broader study of gastrointestinal CYP3A expression. This has allowed the detection of low level CYP3A expression in colonic tissue and demonstration of the heterogeneity in such expression within tissues and between individuals. While the present study clearly shows the application of in situ hybridisation for the precise and sensitive localisation of CYP3A expression in human tissues, complete characterisation of the CYP3A subfamily requires further analysis with probes able to differentiate the highly related CYP3A3 and CYP3A4 sequences. The high sequence similarity of these two P450s will necessitate the use of oligonucleotides probes for differentiation. Oligonucleotide probes have been successfully employed for in situ hybridisation analysis of cytochrome P450 mRNA in rat tissues39 and extension of such studies to human tissues will enable definitive characterisation of intestinal P450 expression and a clearer insight into possible mechanisms of chemical carcinogenesis.
